Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela ...

BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 ...

Newborn screening programme for sickle cell disease (SCD), undertaken between 2019-2024, reduced mortality risk to below 5 ...

Deion Sanders missed CU football camps required by contract. Fans question his absence, but health issues may explain it.

Identifying new drugs for patients with sickle cell disease is very important, said a senior scientist at the Indian Council ...

Stay informed on health matters with Zubeda Hamid's newsletter covering cataract surgeries, maternal health, and medical ...

The room grew quiet Thursday when Tamika Mackey interrupted a craft activity for pediatric hematology and oncology patients ...

Foundation, a nonprofit organization dedicated to providing free life-saving medicines and essential support to individuals ...

A newborn screening programme for sickle cell disease (SCD), conducted between 2019 and 2024, has significantly reduced ...

This might help: The analyst community's current consensus price target of $77.21 is about 75% above this stock's present price. Finally, add Confluent ( CFLT -0.13%) to your list of the best stocks ...

The theme for this year’s commemoration of World Sickle Cell Awareness Day is “Global Action, Local Impact: Empowering ...